Don’t be scared of this drug stock
Elan dropped 10% Tuesday over liver-damage concerns, but the price started inching back up after the FDA clarified its warning. Now's the time to buy the stock while it's still a bargain.
Archive for Investing/StrategyLab/Rnd17/P3/
Follow the new market leaders
Financials may be falling hard, but other segments of the market are healthy. Once the hysteria subsides, a new group of S&P 500 leaders will emerge, and I think these eight stocks will be among them.